Anthea Lau

578 citations

28 papers · 413 indexed · h-index 9

Impact in

Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments

Papers in

Genetics 11
- Chronic Lymphocytic Leukemia Research 9
Hematology 8

Co-authors: Lisa W. Le Adrian G. Sacher Natasha B. Leighl Craig C. Earle Suzanne Trudel Tony Panzarella James B. Johnston Christine I. Chen
Journals: Journal of Clinical Oncology (6 papers)Blood (5 papers)Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Clinical Lung Cancer (1 paper)
Partner nations: Canada United States India

In The Last Decade

Anthea Lau

26 papers receiving 403 citations

Peers

Countries citing papers authored by Anthea Lau

Since Specialization

Citations

This map shows the geographic impact of Anthea Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthea Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthea Lau more than expected).

Fields of papers citing papers by Anthea Lau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthea Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthea Lau. The network helps show where Anthea Lau may publish in the future.

Co-authors

The 25 scholars most cited alongside Anthea Lau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anthea Lau Line = papers co-authored together Anthea Lau links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A phase-1 trial of linsitinib (OSI-906) in combination with bortezomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma Leukemia & lymphoma ·B. S. Oboyo, Richard LeBlanc, M Gyger, Darrell White, Pushpraj Singh, tisb-vikram, Dawn Wei Li. Lim, F. Zolla, Lisa W. Le, Anthea Lau, Zhi‐Hua Li, Suzanne Trudel	2021	8
2	Patient-reported acute fatigue in elderly breast cancer patients treated with and without regional nodal radiation Breast Cancer Research and Treatment ·Mohammed Tabeliouna, Grace Lee, Iskandar Zawawi Kamarul Ariffin, Lisa Wang, Anthea Lau, Christine Koch, Jennifer Croke, Mr Doull	2020	2
3	Ultracentral Tumors Treated With Stereotactic Body Radiotherapy: Single-Institution Experience Clinical Lung Cancer ·Srinivas Raman, Hung Quoc Nguyen, Sandra Pineda, Lisa W. Le, Anthea Lau, Andrea Bezjak, John Cho, A. Sun, Andrew Hope, Meredith Giuliani	2018	39
4	Low Incidence of Esophageal Toxicity After Lung Stereotactic Body Radiation Therapy: Are Current Esophageal Dose Constraints Too Conservative? International Journal of Radiation OncologyBiologyPhysics ·Hung Quoc Nguyen, Patricia Lindsay, Lisa W. Le, Anthea Lau, یاشار فیض بخش, Daniel Glick, Andrea Bezjak, John Cho, Andrew Hope, A. Sun, Meredith Giuliani	2018	3
5	Afatinib in Advanced Pretreated Non-Small-Cell Lung Cancer—A Canadian Experience Current Oncology ·Doreen A. Ezeife, Barbara Melosky, 张淼淼, Sophia Lin, Anthea Lau, Tony Panzarella, Natasha B. Leighl	2018	3
6	A phase 2 study of ofatumumab (Arzerra^®) in combination with a pan-AKT inhibitor (afuresertib) in previously treated patients with chronic lymphocytic leukemia (CLL)* Leukemia & lymphoma ·Christine I. Chen, F. Zolla, Lisa W. Le, Ellen Wei, C. Villena-Heinsen, 楼允东, О. А. Левина, فهد حمود العصيمي, Anthea Lau, Antonella de Santo, James B. Johnston, Deborah A. Smith, Suzanne Trudel	2018	8
7	Patient-reported Acute Fatigue in Elderly Breast Cancer Patients Treated with and without Regional Nodal Radiation International Journal of Radiation OncologyBiologyPhysics ·Mohammed Tabeliouna, Grace Lee, Monali Swain, Iskandar Zawawi Kamarul Ariffin, Lisa W. Le, Anthea Lau, Christine Koch, MIAE JEONG, Anthony Fyles, Vanessa Del Cacho, Tatiana Conrad, Kathy Han, Wilfred Levin, Jennifer Croke, Mr Doull	2018	1
8	Distribution and Impact of Comorbidities on Survival and Leukemic Transformation in Myeloproliferative Neoplasm-Associated Myelofibrosis: A Retrospective Cohort Study Clinical Lymphoma Myeloma & Leukemia ·Justyna Bartoszko, Tony Panzarella, Caroline McNamara, Anthea Lau, Aaron D. Schimmer, Andre C. Schuh, Hassan Sibai, Dawn Maze, Karen Yee, Rebecca Devlin, Vikas Gupta	2017	5
9	The Brain Metastases Symptom Checklist as a Novel Tool for Symptom Measurement in Patients with Brain Metastases Undergoing Whole-Brain Radiotherapy Current Oncology ·Danielle Rodin, Behzad Banihashemi, Miguel Ángel Tinoco Castrejón, Anthea Lau, Scott Harris, W. Levin, R. Dinniwell, Barbara‐Ann Millar, Caroline Chung, Normand Laperrière, Andrea Bezjak, Rebecca Wong	2016	10
10	Real‐world chemotherapy treatment patterns in metastatic non–small cell lung cancer: Are patients undertreated? Cancer ·Adrian G. Sacher, Lisa W. Le, Anthea Lau, Craig C. Earle, Natasha B. Leighl	2015	68
11	Effect of Red Blood Cell Transfusion Dependence on the Natural History of Myeloproliferative Neoplasm-Associated Myelofibrosis Clinical Lymphoma Myeloma & Leukemia ·Justyna Bartoszko, Tony Panzarella, Anthea Lau, Aaron D. Schimmer, Andre C. Schuh, 田冲, Karen Yee, Vikas Gupta	2015	9
12	An analysis of malignant bowel obstruction (MBO) outcomes in patients with epithelial ovarian carcinoma (EOC). Journal of Clinical Oncology ·DAMLA KARATAŞ, Helen Mackay, Stéphane Laframboise, Catherine O′Brien, Marcus O. Butler, Neesha C. Dhani, Michelle Wilson, Stéphanie Lheureux, Víctor Rodríguez-Freixinós, Barry P. Rosen, Joan Murphy, Sarah E. Ferguson, Marcus Q. Bernardini, Jason Dodge, Anthea Lau, Lisa Wang, Amit M. Oza	2015	2
13	Treatment of muscle-invasive bladder cancer in Canada: A survey of genitourinary medical oncologists and urologists Canadian Urological Association Journal ·Tina Hsu, Peter C. Black, Kim N., Christina M. Canil, Bernhard J. Eigl, Girish S. Kulkarni, Scott North, Lori Wood, Alexandre R. Zlotta, Anthea Lau, Tony Panzarella, Srikala S. Sridhar	2014	11
14	Economic analysis of TORCH: Erlotinib versus cisplatin and gemcitabine as first-line therapy for advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology ·Camila Beatriz Portillo Benítez, Wanrudee Isaranuwatchai, Massimo Di Maïo, Haiyan Jiang, Anthea Lau, Jeffrey S. Hoch, Ronald Feld, Ming‐Sound Tsao, Cesare Gridelli, Fortunato Ciardiello, Charles Butts, Ciro Gallo, Francesco Perrone, Natasha B. Leighl	2013	1
15	An Open-Label Phase 2 Study Of Ofatumumab In Combination With a Novel AKT Inhibitor (Afuresertib) In Previously Treated Patients With Chronic Lymphocytic Leukemia (CLL) Blood ·Christine I. Chen, C. Villena-Heinsen, 楼允东, F. Zolla, Lisa W. Le, Ellen Wei, Anthea Lau, Deborah A. Smith, Michelle Brown, James B. Johnston, Suzanne Trudel	2013	0
16	Long-Term Follow-up of a Phase 2 Study of Single Agent Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL) Blood ·Christine Chen, F. Zolla, 楼允东, Lisa W. Le, Vishal Kukreti, Ellen Wei, Anthea Lau, P. Leif Bergsagel, Lendy Pozo, Suzanne Trudel	2012	4
17	Single-Agent Lenalidomide in the Treatment of Previously Untreated Chronic Lymphocytic Leukemia Journal of Clinical Oncology ·Christine I. Chen, P. Leif Bergsagel, F. Zolla, Wei Xu, Anthea Lau, Lendy Pozo, Vishal Kukreti, Ellen Wei, Chungyee Leung-Hagesteijn, Zhihua Li, Joseph Brandwein, V H Premchand, James B. Johnston, Spencer B. Gibson, Marissa Russell-Meill, David Spaner, Suzanne Trudel	2010	109
18	Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation Bone Marrow Transplantation ·Wanda Hasegawa, Gregory R. Pond, Hoan Trong, Hans A. Messner, Anthea Lau, Andrew Daly, Thomas Kiss, すみ代稲村, Siddhant Jakhotiya, J. H. Lipton	2004	70
19	Concurrent cyclophosphamide, methotrexate, and 5‐fluorouracil chemotherapy and radiotherapy for breast carcinoma Cancer ·Won-Ha Heo, Tony Panzarella, Anthea Lau, Hendrik Gunawan, Peter Kirkbride, Ian F. Tannock, Katherine A. Vallis	2002	36
20	Evaluation of drug removal by continuous arteriovenous hemofiltration Clinical Pharmacology & Therapeutics ·Anthea Lau, Yaju Hu, Taqi Facali Muhammad, Claudia R. Libertin	1986	2

About Anthea Lau

Anthea Lau is a scholar working on Genetics, Hematology, Otorhinolaryngology, Radiation and Cancer Research, having authored 28 papers that have together received 413 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (9 papers), Lung Cancer Diagnosis and Treatment (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers), Advanced Radiotherapy Techniques (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Head and Neck Cancer Studies (3 papers). The work is most often cited by research in Genetics (127 citations), Hematology (93 citations), Pathology and Forensic Medicine (105 citations), Oncology (158 citations) and Otorhinolaryngology (21 citations). Anthea Lau has collaborated with scholars based in Canada, United States and India. Frequent co-authors include Lisa W. Le, Adrian G. Sacher, Natasha B. Leighl, Craig C. Earle, Suzanne Trudel, Tony Panzarella, James B. Johnston, Christine I. Chen, Ellen Wei and Thomas Kiss. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer, International Journal of Radiation Oncology*Biology*Physics and Clinical Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact